ADMA Biologics
ADMA
ADMA
163 hedge funds and large institutions have $547M invested in ADMA Biologics in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 43 reducing their positions, and 18 closing their positions.
Holders
163
Holders Change
+3
Holders Change %
+1.88%
% of All Funds
2.61%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
25
Increased
64
Reduced
43
Closed
18
Calls
$2.01M
Puts
$930K
Net Calls
+$1.08M
Net Calls Change
-$8.69M
Top Buyers
1 |
1
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$22.1M |
2 |
2
State Street
Boston,
Massachusetts
|
$43M |
3 |
3
Nuveen Asset Management
Chicago,
Illinois
|
$29.9M |
4 |
4
Two Sigma Advisers
New York
|
$6.65M |
5 |
5
BlackRock
New York
|
$54.3M |